The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

Discover the history, evolution, and importance of clinical trials, from James Lind's scurvy study to modern registry ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ...

Phase 3 Top Line Results Expected Q2 2026 SALT LAKE CITY, June 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its ...

The traditional approach to trial management relies on a mix of solutions that often become siloed and difficult to integrate ...

Phase 3 study met primary and most key secondary clinical endpoints This marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Accurate medication reconciliation is essential in early-phase oncology clinical trials, where drug-drug interactions (DDIs), eligibility criteria, and patient safety are closely scrutinized. 1 ...